EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 170 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $21,000 | +23.5% | 425 | 0.0% | 0.00% | +100.0% |
| Q4 2018 | $17,000 | -71.2% | 425 | -50.1% | 0.00% | -75.0% |
| Q3 2018 | $59,000 | -15.7% | 852 | -7.9% | 0.00% | -20.0% |
| Q2 2018 | $70,000 | +34.6% | 925 | -7.3% | 0.01% | +66.7% |
| Q1 2018 | $52,000 | -96.8% | 998 | -96.7% | 0.00% | -96.3% |
| Q4 2017 | $1,618,000 | -10.3% | 30,289 | +0.2% | 0.08% | +10.8% |
| Q3 2017 | $1,803,000 | +30.8% | 30,233 | +73.1% | 0.07% | +42.3% |
| Q2 2017 | $1,378,000 | – | 17,465 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 112,666 | $1,777 | 0.65% |
| Smith, Graham & Co., Investment Advisors, LP | 273,099 | $4,306,771 | 0.54% |
| BRANDES INVESTMENT PARTNERS, LP | 1,134,363 | $17,888,904 | 0.35% |
| TANG CAPITAL MANAGEMENT LLC | 118,857 | $1,874,375 | 0.26% |
| Virtus Investment Advisers, Inc. | 20,867 | $329,073 | 0.22% |
| DENALI ADVISORS LLC | 32,300 | $509,371 | 0.18% |
| Nebula Research & Development LLC | 11,473 | $180,929 | 0.10% |
| SCOUT INVESTMENTS, INC. | 131,192 | $1,995,430 | 0.05% |
| XTX Topco Ltd | 15,050 | $237,339 | 0.04% |
| PDT Partners, LLC | 19,745 | $311,379 | 0.04% |